Jenoptik AG

Informe acción XTRA:JEN

Capitalización de mercado: €1.1b

Salud financiera de hoja de balance de Jenoptik

Salud financiera controles de criterios 5/6

Jenoptik tiene un patrimonio de accionistas total de €971.7M y una deuda total de €433.4M, lo que sitúa su ratio deuda-patrimonio en 44.6%. Sus activos y pasivos totales son €1.7B y €712.7M respectivamente. El BAIT de Jenoptik es de €138.0M, por lo que su ratio de cobertura de intereses es de 6.6. Tiene efectivo e inversiones a corto plazo que ascienden a €50.2M.

Información clave

44.61%

Ratio deuda-patrimonio

€433.43m

Deuda

Ratio de cobertura de intereses6.6x
Efectivo€50.18m
Patrimonio€971.67m
Total pasivo€712.68m
Activos totales€1.68b

Actualizaciones recientes sobre salud financiera

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Jan 13
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

May 30
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Is Jenoptik (ETR:JEN) A Risky Investment?

Dec 20
Is Jenoptik (ETR:JEN) A Risky Investment?

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Jul 25
Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Apr 04
We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Dec 06
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Recent updates

Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

May 16
Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

Jenoptik (ETR:JEN) Is Paying Out A Larger Dividend Than Last Year

Apr 30
Jenoptik (ETR:JEN) Is Paying Out A Larger Dividend Than Last Year

Are Investors Undervaluing Jenoptik AG (ETR:JEN) By 34%?

Apr 20
Are Investors Undervaluing Jenoptik AG (ETR:JEN) By 34%?

Benign Growth For Jenoptik AG (ETR:JEN) Underpins Stock's 34% Plummet

Apr 05
Benign Growth For Jenoptik AG (ETR:JEN) Underpins Stock's 34% Plummet

At €23.20, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Feb 27
At €23.20, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?
author-image

Investments In Dresden Facility And Diversification Will Support Future Performance

Strategic investments in semiconductor capacity and sales channels bolster future growth, helping offset market volatility and enhance revenue potential.

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Jan 13
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 15
Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Nov 14
Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Oct 14
Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

Sep 28
Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

Aug 15
Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Jun 12
Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

May 30
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

Apr 25
Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

Apr 15
Jenoptik AG's (ETR:JEN) P/E Is On The Mark

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Mar 30
Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Mar 22
At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

Jan 07
Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

Is Jenoptik (ETR:JEN) A Risky Investment?

Dec 20
Is Jenoptik (ETR:JEN) A Risky Investment?

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

Dec 05
Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Sep 01
Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Aug 11
Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Jul 25
Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

May 07
Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Apr 04
We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Should You Think About Buying Jenoptik AG (ETR:JEN) Now?

Feb 19
Should You Think About Buying Jenoptik AG (ETR:JEN) Now?

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Dec 06
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Nov 13
What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?

Oct 28
Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?

Is Jenoptik (ETR:JEN) A Risky Investment?

Sep 02
Is Jenoptik (ETR:JEN) A Risky Investment?

When Should You Buy Jenoptik AG (ETR:JEN)?

Aug 13
When Should You Buy Jenoptik AG (ETR:JEN)?

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

May 19
We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?

May 01
Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Feb 14
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?

Jan 23
Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?

Is Jenoptik (ETR:JEN) Using Too Much Debt?

Nov 07
Is Jenoptik (ETR:JEN) Using Too Much Debt?

At €32.08, Is It Time To Put Jenoptik AG (ETR:JEN) On Your Watch List?

Oct 23
At €32.08, Is It Time To Put Jenoptik AG (ETR:JEN) On Your Watch List?

Here's What To Make Of Jenoptik's (ETR:JEN) Decelerating Rates Of Return

Sep 23
Here's What To Make Of Jenoptik's (ETR:JEN) Decelerating Rates Of Return

Estimating The Fair Value Of Jenoptik AG (ETR:JEN)

Aug 28
Estimating The Fair Value Of Jenoptik AG (ETR:JEN)

Is Jenoptik (ETR:JEN) Using Too Much Debt?

Jul 27
Is Jenoptik (ETR:JEN) Using Too Much Debt?

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Jul 13
Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (€558.1M) de JEN superan a sus pasivos a corto plazo (€366.8M).

Pasivo a largo plazo: Los activos a corto plazo de JEN (€558.1M) superan a sus pasivos a largo plazo (€345.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (39.4%) de JEN se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de JEN ha crecido de 27.3% a 44.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de JEN está bien cubierta por el flujo de caja operativo (41.5%).

Cobertura de intereses: Los pagos de intereses de la deuda de JEN están bien cubiertos por el BAIT (6.6x cobertura).

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2025/05/28 06:04
Precio de las acciones al final del día2025/05/28 00:00
Beneficios2025/03/31
Ingresos anuales2024/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Jenoptik AG está cubierta por 22 analistas. 10 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Peter RothenaicherBaader Helvea Equity Research
Lasse StuebenBerenberg
Michele BaldelliBNP Paribas Exane